Earnings · China A-shares
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Class A (301093) earnings
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit -39.58% year on year, -55.94% excluding one-off items. Wave Radar's earnings-quality score is 90 of 100 (Sound). The stock moved -6.50% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -39.58%
- Excl. one-offs YoY
- -55.94%
- Net profit QoQ
- +247.43%
- Result
- Bad / loss
- Quality score
- 90
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -6.13% | — |
| 3 days | -6.50% | — |
| 7 days | -6.54% | — |
| 14 days | -14.82% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 3 of 7 reports (average +1.23%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥32.21M | -39.58% | -55.94% | +4.30% | 0.15 | 1.47% | -6.50% | — | — |
| 2026 interim report | 2026-08-27 | ¥7.67M | -82.46% | — | -3.47% | 0.04 | 0.35% | -1.35% | -31.41% | -22.47% |
| 2026 Q1 report | 2026-04-24 | ¥609.65K | -96.68% | — | -11.00% | 0.00 | 0.03% | +5.81% | +67.12% | +66.70% |
| 2025 annual report | 2026-04-24 | ¥60.18M | +21.39% | +18.63% | +5.63% | 0.37 | 2.70% | +5.81% | +67.12% | +66.70% |
| 2025 Q3 report | 2025-10-23 | ¥53.32M | +2.06% | +13.66% | +4.36% | 0.33 | 2.37% | +3.57% | +21.88% | +22.75% |
| 2025 interim report | 2025-08-27 | ¥43.73M | +18.27% | +42.18% | +8.82% | 0.27 | 1.93% | -3.17% | +7.51% | +3.73% |
| 2025 Q1 report | 2025-04-28 | ¥18.38M | +72.10% | +273.62% | +15.03% | 0.11 | 0.82% | -4.12% | +5.96% | +2.72% |
| 2024 annual report | 2025-04-21 | ¥49.57M | -57.96% | -40.79% | -5.86% | 0.30 | 2.12% | +14.37% | +22.42% | +19.47% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.